A Novel Anti-Human Syndecan-1 (CD138) Monoclonal Antibody 4B3: Characterization and Application

被引:1
|
作者
Wanping Sun1
2Physiology Department of Basic Medical School
3Stem Cell Research Laboratory of Jiangsu Province
机构
关键词
syndecan-1(CD138); monoclonal antibody; multiple myeloma;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Syndecan-1 (CD138), a member of integral membrane heparin sulfate proteoglycans, is an essential matrix receptor for maintaining the normal morphological phenotypes. In this study, we generated a specific mouse anti-human syndecan-1 monoclonal antibody (mAb) 4B3 and identified it by competition assay with the available syndecan-1 mAb (BB4). Stained by 4B3, the expression of syndecan-1 was detected on tumor cell lines, such as 8226, U266, XG-1, XG-2, Daudi and Jurkat. The expression was also found on neuron stem cells. It was established that 4B3 mAb could inhibit XG-1 and XG-2 proliferation. The data not only determined that 4B3 mAb was a functional anti-human syndecan-1 mAb, but also indicated that syndecan-1 might be a valuable surface antigen and play an important role in regulation of tumor pathology and differentiation of neural stem cells. This novel antibody 4B3 may be value of study of tumor proliferation/survival mechanism and contributes to diagnosis and treatment of diverse diseases.
引用
收藏
页码:209 / 214
页数:6
相关论文
共 50 条
  • [21] Characterization of immunological and molecular properties of an anti-human 4-1BB monoclonal antibody
    Lee, SH
    Lee, NG
    Suh, SY
    Kim, JG
    Choi, EC
    Kang, CY
    MOLECULES AND CELLS, 1996, 6 (02) : 161 - 168
  • [22] Anti-human 4-1BB ligand monoclonal antibody (clone1F1) or anti-human CD137 ligand monoclonal antibody (clone1F1)
    Zhang, XG
    HYBRIDOMA AND HYBRIDOMICS, 2003, 22 (06): : 407 - 407
  • [23] Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas
    Carbone, A
    Gloghini, A
    Larocca, LM
    Capello, D
    Pierconti, F
    Canzonieri, V
    Tirelli, U
    Dalla-Favera, R
    Gaidano, G
    BLOOD, 2001, 97 (03) : 744 - 751
  • [24] The heparan sulphate proteoglycan Syndecan-1 (CD138) regulates tumour progression in a 3D model of ductal carcinoma in situ of the breast
    D'Arcy, Christopher
    Zimmermann, Clarissa Constanze
    Espinoza-Sanchez, Nancy Adriana
    Greve, Burkhard
    Schmidt, Annika
    Kiesel, Ludwig
    von Wahlde, Marie-Kristin
    Goette, Martin
    IUBMB LIFE, 2022, 74 (10) : 955 - 968
  • [25] Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins
    Jung, O.
    Trapp-Stamborski, V.
    Purushothaman, A.
    Jin, H.
    Wang, H.
    Sanderson, R. D.
    Rapraeger, A. C.
    ONCOGENESIS, 2016, 5 : e202 - e202
  • [26] Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins
    O Jung
    V Trapp-Stamborski
    A Purushothaman
    H Jin
    H Wang
    R D Sanderson
    A C Rapraeger
    Oncogenesis, 2016, 5 : e202 - e202
  • [27] Establishment and usefulness of an anti-human CD57 IgG1 monoclonal antibody
    Tajima, J
    Heike, Y
    Kato, K
    Ikarashi, Y
    Asada-Mikami, R
    Yoshida, M
    Kasahara, T
    Wakasugi, H
    IMMUNOLOGY LETTERS, 2000, 72 (03) : 159 - 162
  • [28] In vitro characterization of anti-angiogenic effects of DS-7080a, a novel anti-human ROBO4 monoclonal antibody
    Isumi, Yoshitaka
    Inoue, Tatsuya
    Hayashi, Shinko
    Yoshimura, Chigusa
    Hasegawa, Jun
    Sato, Toshiyuki
    Agatsuma, Toshinori
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [29] Characterization of a surrogate murine antibody to model anti-human CD3 therapies
    Depis, Fabien
    Hatterer, Eric
    Ballet, Romain
    Daubeuf, Bruno
    Cons, Laura
    Glatt, Sophie
    Reith, Walter
    Kosco-Vilbois, Marie
    Dean, Yann
    MABS, 2013, 5 (04) : 555 - 564
  • [30] Syndecan-1 (CD138) modulates breast cancer stem cell properties via regulation of IL-6-mediated STAT3 signaling
    Ibrahim, S. A.
    Hassan, H.
    Greve, B.
    Kelsch, R.
    Kiesel, L.
    Reinbold, R.
    Goette, M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2013, 121 (03)